E-LIB Suche - Ergebnisse für: Mekhail, T.

1

P2.27-03 Perception of Benefits and Risks of Treatments in ..:

Horn, M. ; Curran, E. ; Seo, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S401-S402 , 2023

Link: https://doi.org/10.1016/..

2

EP03.01-02 Molecular Characterization of Non-small Cell Lun..:

Aggarwal, V. ; Xiu, J. ; Nagasaka, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S439-S440 , 2023

Link: https://doi.org/10.1016/..

3

EP08.02-171 PRO-CTCAE Analysis of Mobocertinib in EGFR Exon..:

García Campelo, M.R. ; Zhou, C. ; Ramalingam, S.S....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S487-S488 , 2022

Link: https://doi.org/10.1016/..

4

PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study o..:

Antonia, S.J. ; Villegas, A. ; Daniel, D....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 5 - p. 1314-1315 , 2017

Link: https://doi.org/10.1016/..

5

3101 Updated efficacy and safety results from a global phas..:

Barlesi, F. ; Dingemans, A.M.C. ; Ou, I....
European Journal of Cancer. 51 (2015) - p. S635 , 2015

Link: https://doi.org/10.1016/..

6

3009 Activity of rociletinib in EGFR mutant NSCLC patients ..:

Varga, A. ; Camidge, D.R. ; Sequist, L.V....
European Journal of Cancer. 51 (2015) - p. S598 , 2015

Link: https://doi.org/10.1016/..

7

Efficacy and Safety of Onartuzumab in Combination With Firs..:

Wakelee, H.A. ; Zvirbule, Z. ; De Braud, F....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S37-S38 , 2014

Link: https://doi.org/10.1016/..

8

10LBA Interim phase 2 results of study CO-1686-008: A phase..:

Soria, J. ; Sequist, L.V. ; Goldman, J.W....
European Journal of Cancer. 50 (2014) - p. 199 , 2014

Link: https://doi.org/10.1016/..

9

Phase I/II Trial of the Addition of Erlotinib to Pre- and P..:

Videtic, G.M. ; Rice, T. ; Murthy, S....
International Journal of Radiation Oncology*Biology*Physics. 75 (2009) 3 - p. S58 , 2009

Link: https://doi.org/10.1016/..

10

Pleural Mesothelioma Treated with Induction Platinum Based ..:

Murphy, E.S. ; Pavelecky, N.N. ; Reddy, C.A....
International Journal of Radiation Oncology*Biology*Physics. 75 (2009) 3 - p. S442-S443 , 2009

Link: https://doi.org/10.1016/..

11

New Classification Scheme to Predict Survival in Patients w..:

Chao, S.T. ; Elson, P. ; Angelov, L....
International Journal of Radiation Oncology*Biology*Physics. 72 (2008) 1 - p. S214-S215 , 2008

Link: https://doi.org/10.1016/..

12

Phase Ι trial of weekly Docetaxel and daily Temozolomide in..:

Tamaskar, I. ; Mekhail, T. ; Dreicer, R....
Investigational New Drugs. 26 (2008) 6 - p. 553-559 , 2008

Link: https://doi.org/10.1007/..

13

416 POSTER Phase I trial of ixabepilone administered as a 2..:

Tan, A.R. ; Mekhail, T. ; Edelman, M.J....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 131 , 2008

Link: https://doi.org/10.1016/..

14

Daily Subcutaneous Amifostine Facilitates Radiation Dose Es..:

Videtic, G.M. ; Desai, A. ; Reddy, C...
International Journal of Radiation Oncology*Biology*Physics. 69 (2007) 3 - p. S487-S488 , 2007

Link: https://doi.org/10.1016/..

15

Phase I trial of three-weekly Docetaxel, Carboplatin and or..:

Kalmadi, S. ; Davis, M. ; Dowlati, A....
Investigational New Drugs. 25 (2006) 3 - p. 211-216 , 2006

Link: https://doi.org/10.1007/..